| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 109.28B | 111.05B | 104.28B | 97.91B | 87.62B | 71.83B |
| Gross Profit | 39.04B | 39.49B | 34.59B | 33.74B | 28.03B | 20.35B |
| EBITDA | 11.19B | 11.82B | 8.45B | 9.11B | 9.43B | 717.00M |
| Net Income | 7.05B | 7.25B | 4.64B | 5.72B | 6.16B | -2.07B |
Balance Sheet | ||||||
| Total Assets | 181.56B | 172.91B | 167.59B | 165.52B | 157.08B | 144.44B |
| Cash, Cash Equivalents and Short-Term Investments | 62.56B | 59.47B | 50.61B | 63.36B | 63.92B | 55.48B |
| Total Debt | 19.96B | 12.24B | 11.56B | 11.31B | 11.90B | 11.97B |
| Total Liabilities | 68.22B | 57.41B | 53.12B | 58.39B | 53.70B | 46.70B |
| Stockholders Equity | 113.33B | 115.50B | 114.47B | 106.97B | 103.29B | 97.67B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 14.74B | -9.60B | 2.76B | 7.36B | 7.04B |
| Operating Cash Flow | 0.00 | 17.02B | -8.05B | 4.47B | 9.28B | 8.17B |
| Investing Cash Flow | 0.00 | -4.78B | 483.00M | -526.00M | -1.38B | -2.22B |
| Financing Cash Flow | 0.00 | -4.31B | -4.87B | -4.08B | -2.94B | 9.29B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥96.28B | 136.93 | 5.02% | 3.23% | -10.00% | -51.92% | |
78 Outperform | ¥120.88B | 12.40 | ― | 3.24% | 18.70% | 33.93% | |
77 Outperform | ¥83.62B | 7.02 | 8.33% | 5.31% | 5.45% | 90.90% | |
75 Outperform | ¥65.74B | 13.24 | ― | 3.95% | -1.67% | -4.39% | |
75 Outperform | ¥145.44B | 12.83 | ― | 3.47% | 3.93% | 68.67% | |
74 Outperform | ¥60.34B | 24.26 | ― | 2.54% | 2.00% | 39.80% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |